Leymus Genomics ApS: Financial statements 2022
CVR: 38106872
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Leymus Genomics ApS (CVR 38106872) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 332,776 and a net result of DKK -1,655,772 compared with DKK 3,044,086 the year before. That is a decrease of 94.5% compared with the year before. Equity in the 2022 report amounted to DKK 1,144,463. The solvency ratio was 89.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 332,776
- Profit/Loss
- DKK -1,655,772
- Equity
- DKK 1,144,463
- Total Assets
- DKK 1,278,362
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 333K | -1.7M | 1.1M | 3 |
| 2021 | - | 6.1M | 3M | 3.7M | 4 |
| 2020 | - | 604K | 347K | 638K | 1 |
| 2019 | - | -156K | -370K | 291K | - |
| 2018 | - | -186K | -228K | 161K | - |
Official annual report
Keep an eye on Leymus Genomics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Leymus Genomics ApS has published its annual report for 2021. Gross profit came to DKK 6,081,520, and the net result was DKK 3,044,086.
About Leymus Genomics ApS
Leymus Genomics ApS was a Danish company of the type Anpartsselskab based in Herlev, founded in 2016. The company has been dissolved on 28 November 2024. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Leymus Scientific Capital ApS. The company has 3 employees (2023). In 2023, the company reported a gross profit of DKK -1,341,461 and a net result of DKK -1,269,016 compared with DKK -1,655,772 the year before. Equity in the 2023 report amounted to DKK -124,553.